RecruitingNCT04465838

Chinese Psoriasis Real World Evidence Research

A Real World Evidence Study in Chinese Psoriasis Patients

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

10,000 participants

Start Date

Jul 8, 2020

Study Type

OBSERVATIONAL

Conditions

Psoriasis

Summary

This research is a multicenter,observational study under real world settings in patients diagnosed as psoriasis by dermatologist in the clinic. As patient's choice of medication should be fully respected, all the patients can choose the treatments they prefer, like phototherapy, traditional systemic therapy or biologics. And the study was conducted to compare the effectiveness among different choices of medication in Chinese psoriasis patients.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NIS for people with psoriasis. The study is currently recruiting participants at 29 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNIS

This is a non-interventional study (NIS).

Locations(29)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

Beijing Children's Hospital Affiliated to Capital Medical University

Beijing, China

the First Affiliated Hospital of Chongqing Medical University

Chongqing, China

the First Affiliated Hospital of Fujian Medical University

Fujian, China

General Hospital of Lanzhou Military Region

Gansu, China

Sun Yat-sen Memorial Hospital

Guangdong, China

The Peoples' Hospital of Guangxi Zhuang Autonomous Region

Guangxi, China

the Affiliated Hospital of Guizhou Medical University

Guizhou, China

The Fifth People's Hospital of Hainan Province

Hainan, China

the First Hospital of Hebei Medical University

Hebei, China

the Second Affiliated Hospital of Harbin Medical Unviersity

Heilongjiang, China

Henan Provincial Peoples' Hospital

Henan, China

the Affiliated Hospital of Inner Mongolia Medical University

Hohhot, China

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Hubei, China

Xiangya Hospital, Central South University

Hunan, China

the Second Affiliated Hospital of Nanchang University

Jiangxi, China

Yanbian University Hospital

Jilin City, China

Institute of Dermatology, Chinese Academy of Medical Sciences

Nanjing, China

Xining First Hospital

Qinghai, China

Shandong Provincial Hospital for Skin Diseases

Shandong, China

Shanghai Dermatology Hospital

Shanghai, China

Taiyuan Central Hospital

Shanxi, China

the Second Affiliated Hospital of Xi'an Jiaotong University

Shanxi, China

the First hospital of China Medical University

Shenyang, China

Sichuan Provincial People's Hospital

Sichuan, China

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital

Tianjin, China

First Affiliated Hospital, School of Medicine, Shihezi University

Xinjiang, China

General Hospital of Ningxia Medical University

Yinchuan, China

the Second Affiliated Hospital of Kunming Medical University

Yunnan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04465838

Related Trials

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet

NCT065741781 location

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

NCT076486022 locations

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

NCT065994111 location

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT0381634552 locations

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

NCT075827836 locations